Navigation Links
Possible treatment for serious blood cancer
Date:5/6/2013

A single antibody could be the key to treating multiple myeloma, or cancer of the blood, currently without cure or long-term treatment.

"We tested the antibody in various ways, including on tumour cells from myeloma patients that have been transplanted into mice. The tests showed that the antibody is able to destroy myeloma cells", explains Markus Hansson, a researcher at Lund University in Sweden.

Using a 'biological library' of thousands of antibodies from the company BioInvent in Lund, the team singled out antibody BI-505, shown to have a powerful effect on the tumour cells in both cell studies and animal experiments. It has also been tested in an initial safety study on seriously ill patients, and a study of its treatment effects has just started.

"This study will include patients who have just been diagnosed and therefore still feel fairly well. We want to test the antibody treatment before the patients are treated with any other drugs", says Markus Hansson.

Today there are a number of drugs to treat multiple myeloma, but no cure. None of the drugs are able to eradicate the disease, meaning cancer cells increase in number after a period of remission. Survival has been extended with new treatments, but less than half of all patients live longer than five years from diagnosis.

Myeloma occurs when a specific type of cell in the bone marrow is converted into tumour cells. Blood formation is disrupted and patients suffer from a lack of blood resulting in fatigue. The bones can be weakened with a risk of fractures and compacted vertebrae, and patients sometimes suffer kidney failure as a result of the disease.

Antibodies are a part of the immune system, fighting off foreign bodies. Antibody-based drugs are now used to treat certain inflammatory diseases and types of cancer.

The treatment study in Lund will involve 15 patients and is expected to be completed this year. If the results are good, Markus Hansson
'/>"/>

Contact: Markus Hansson
markus.hansson@med.lu.se
46-705-931-110
Lund University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Zamansky & Associates LLC Investigates Chemed Corporation For Possible Securities Law Violations And Breaches Of Fiduciary Duties To Shareholders
2. US Drug Watchdog Is Expanding Their Transvaginal Mesh Failure Initiative And They Are Urging Victims To Call Them For The Names Of The Best Possible Women Lawyers To Help
3. Lung Cancer Asbestos Victims Center Now Urges Any Type Of Lung Cancer Victim Who Was Exposed To Asbestos At Work To Call Them About Possible Significant Compensation
4. Personal Injury Lawyer Sean M. Cleary Warns Resort Vacationers about Possible Accidents and Injuries
5. Lung Cancer Asbestos Victims Center Now Urges All Lung Cancer Victims To Call Them If They Were Exposed To Asbestos In Their Place Of Work-Possible Major Compensation
6. Pancreatic Cancer Correlation to Type 2 Diabetes Drugs Januvia and Byetta, New Studies Find Possible Connection
7. Lung Cancer Asbestos Victims Center Now Urges All US Citizens With Any Type Of Lung Cancer To Call Them About Possible Compensation-Were You Exposed To Asbestos
8. Lung Cancer Asbestos Victims Center Now Urges Lung Cancer Victims Who Are Nonsmokers And Were Exposed To Asbestos On The Job To Call Them-Possible Major Compensation
9. Battle for Grace: A Memoir of Pain, Redemption and Impossible Love
10. US Drug Watchdog Now Urges Transvaginal Mesh Failure Victims With A Failed Revision Surgery to Call Them for the Names of the Best Possible Women Attorneys
11. Lung Cancer Asbestos Victims Center Now Urges Nonsmoker Lung Cancer Victims Who Were exposed To Asbestos In Their Workplace To Call Them About Possible Compensation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2014 West Hollywood cosmetic dentist ... for Invisalign. This special offer includes a free consultation ... determine their candidacy for the procedure and answer any ... may also be eligible for the Summer Invisalign special, ... the month of August, patients who choose Invisalign will ...
(Date:9/2/2014)... Dennis Thompson HealthDay Reporter ... early or at low birth weight are at risk later ... problems that increase their risk for heart disease, according to ... children face potential lifetime disadvantages, researchers in both studies ... found that these obstacles can be overcome. Education appeared ...
(Date:9/2/2014)... 02, 2014 Moroccan Eco-Biologics’ new one-of-a-kind ... formulated, while preserving the foundation of all natural Moroccan ... and scalp problems. There is nothing similar to Vitality ... , Hair loss is a commonly encountered problem for ... for treatment have been limited to existing medications offering ...
(Date:9/2/2014)... 02, 2014 USARAD Holdings Inc. ... telemedicine solutions provider, including SecondOpinions.com® – consumer division ... technologically advanced services. The telemedicine industry pioneer is ... Kuwait. , Founded and established in 1963 as ... Shifa began as a maternity care hospital with ...
(Date:9/2/2014)... 02, 2014 The global market for ... million by 2020, growing at an estimated CAGR of ... study by Grand View Research, Inc. Peripheral vascular devices ... devices are used for treating peripheral arterial or coronary ... plaques in arteries. These devices are used to decrease ...
Breaking Medicine News(10 mins):Health News:West Hollywood Cosmetic Dentist, Dr. Poneh Ghasri, Now Offers Complimentary Consultations for Invisalign 2Health News:Preterm or Small Birth Tied to Long-Term Risks to Heart, Brain 2Health News:Preterm or Small Birth Tied to Long-Term Risks to Heart, Brain 3Health News:New All Natural, Organic Hair Recovery Products by Moroccan Eco-Biologics, Restore Lost Hair with No Side Effects 2Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 2Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 3Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 4Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 2Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 3Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 4Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 5
... who wear bifocal lenses to help them focus accurately may ... new research from Cardiff University. , The Cardiff School of ... the reasons for poor focussing among children with Downs syndrome. ... study who adopted bifocals to ease difficulties in focusing on ...
... April 29 BioElectronics,Corporation, (Pink Sheets: BIEL), announced ... the ActiPatch products to the Italian market. TSS ... both pharmacies,and consumers in Italy. TSS Medical is ... and is headquartered in Torino, Italy. Over,10,000 ActiPatch ...
... ... Characteristics of New Drugs, BOSTON, April 29 ... provider of commercial open-source "R",software for computational statistics, today released ... Quad-Core AMD,Systems," a study conducted in partnership with Pfizer on ...
... get them at the wrong time, CDC study finds , , ... more than a quarter of American toddlers may be under-vaccinated. ... months found that missed doses account for about two-thirds of ... issue, according to a study conducted by the U.S. Centers ...
... HCA announces the,following Webcast:, What: ... 9:00am CT, Where: http://www.videonewswire.com/event.asp?id=47214 , How: ... on to the web at the ... to participate during the live webcast, the call will,be archived on the ...
... management expertise to executive role, SEATTLE, April ... the appointment of John Havard as the company,s ... 21 years experience,to the Stratos team of product ... as some of the best talent,in complex technology ...
Cached Medicine News:Health News:A life 'lens' ordinary 2Health News:BioElectronics Corporation Announces New Website for Italian Market 2Health News:BioElectronics Corporation Announces New Website for Italian Market 3Health News:Pfizer Partners with REvolution Computing to Improve Medicine Production Pipeline 2Health News:Pfizer Partners with REvolution Computing to Improve Medicine Production Pipeline 3Health News:1 in 4 U.S. Toddlers Improperly Vaccinated 2Health News:1 in 4 U.S. Toddlers Improperly Vaccinated 3Health News:Stratos Product Development Welcomes Back John Havard as Vice President of Engineering 2
(Date:9/2/2014)... 2, 2014   Intrexon Corporation (NYSE: ... announced that it has entered into an Exclusive Channel ... of Sanofi (EURONEXT: SAN and NYSE: SNY ... specific family of its marketed Active Pharmaceutical Ingredients (APIs) ... . This collaboration will leverage Intrexon,s proprietary technology ...
(Date:9/2/2014)... Calif. , Sept. 2, 2014 Cepheid ... Flu/RSV XC, an on-demand molecular test for ... Flu B, and differentiation of RSV infection. The ... under the European Directive on In Vitro ... of tests available to eighteen. Xpert Flu/RSV XC runs ...
(Date:9/2/2014)... -- Sinovac Biotech Ltd. (NASDAQ: SVA ), a leading ... today announced that the Company,s management will participate in the ... Global Healthcare Conference, to be held at the Grand Hyatt ... Morgan Stanley Asia Pacific Healthcare Day, to be held at ... Aegis Healthcare & Technology Conference, to be held at the ...
Breaking Medicine Technology:Intrexon Announces Exclusive Channel Collaboration with Sanofi to Optimize Production for a Specific Family of Active Pharmaceutical Ingredients 2Intrexon Announces Exclusive Channel Collaboration with Sanofi to Optimize Production for a Specific Family of Active Pharmaceutical Ingredients 3Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection 2Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection 3Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection 4Sinovac to Participate in Upcoming Investor Conferences 2
... VirtualScopics, Inc. (Nasdaq: VSCP ), a leading provider of ... balance (the amount remaining to be recognized from its active ... the clinical research industry), exceeds $35 million which compares to ... greater than 90% increase. The average duration of the studies ...
... Sparta Systems, Inc., the maker of TrackWise® software ... compliance solutions, today announced that Ascent Healthcare Solutions, ... has selected its TrackWise Enterprise Quality Management System ... compliance with industry regulations. Ascent will deploy ...
Cached Medicine Technology:VirtualScopics' Project Balance Exceeds a Record $35 Million 2VirtualScopics' Project Balance Exceeds a Record $35 Million 3Leading Medical Device Provider Chooses TrackWise(R) Software to Optimize Customer Complaint Handling 2Leading Medical Device Provider Chooses TrackWise(R) Software to Optimize Customer Complaint Handling 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: